Cargando…

α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis

Systemic sclerosis is a connective tissue disease of unknown origin that is characterized by immune system abnormalities, vascular damage, and extensive fibrosis of the skin and visceral organs. α2-antiplasmin is known to be the main plasmin inhibitor and has various functions such as cell different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanno, Yosuke, Shu, En
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953682/ https://www.ncbi.nlm.nih.gov/pubmed/35330147 http://dx.doi.org/10.3390/life12030396

Ejemplares similares

Altered Behavior in Mice with Deletion of the Alpha2-Antiplasmin Gene
por: Kawashita, Eri, et al.
Publicado: (2014)

Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine
por: Liu, Jialu, et al.
Publicado: (2022)

α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis
por: Kanno, Yosuke, et al.
Publicado: (2017)

α2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline
por: Kawashita, Eri, et al.
Publicado: (2020)

Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology
por: Kangro, Kadri, et al.
Publicado: (2023)

Increased urokinase and consumption of α(2)‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay
por: Longstaff, C., et al.
Publicado: (2018)

Alpha 2-antiplasmin deficiency in a Sudanese child: a case report
por: Mohammed, Bashir Abdrhman Bashir
Publicado: (2021)

Association of Genetic Polymorphisms of Fibrinogen, Factor XIII A-Subunit and α(2)-Antiplasmin with Fibrinogen Levels in Pregnant Women
por: Schwedler, Christian, et al.
Publicado: (2021)

Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin
por: Abdul, Shiraazkhan, et al.
Publicado: (2018)

Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
por: Singh, Satish, et al.
Publicado: (2020)

Performance evaluation of thrombomodulin, thrombin‐antithrombin complex, plasmin‐α2‐antiplasmin complex, and t‐PA: PAI‐1 complex
por: Chen, Qian, et al.
Publicado: (2019)

Alpha II Antiplasmin Deficiency Complicating Pregnancy: A Case Report
por: Dawley, Brenda
Publicado: (2011)

The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
por: Kanno, Yosuke
Publicado: (2019)

Addition of a sequence from α(2)-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
por: Sheffield, William P, et al.
Publicado: (2009)

Therapeutic targets in systemic sclerosis
por: Denton, Christopher P
Publicado: (2007)

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form
por: Abdul, Shiraazkhan, et al.
Publicado: (2020)

Serum apolipoprotein A-II and alpha-2-antiplasmin levels in midtrimester can be used as predictors of preterm delivery
por: Huang, Jianxia, et al.
Publicado: (2020)

Relation of α(2)-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
por: Hoppe, Berthold, et al.
Publicado: (2020)

Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea
por: Zakrzewski, Maciej, et al.
Publicado: (2016)

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
por: Sugioka, Koji, et al.
Publicado: (2012)

Plasma centrifugation does not influence thrombin-antithrombin and plasmin-antiplasmin levels but determines platelet microparticles count
por: Stępień, Ewa, et al.
Publicado: (2015)

Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson’s Disease
por: Sharma, Amit, et al.
Publicado: (2021)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
por: Kim, Suhee, et al.
Publicado: (2022)

Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
por: Govindarajan, Vaidya, et al.
Publicado: (2020)

CD146: a potential therapeutic target for systemic sclerosis
por: Zhang, Lingling, et al.
Publicado: (2018)

Gut microbiome in systemic sclerosis: a potential therapeutic target
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020)

Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis: The role of alternatively activated macrophages on the development of fibrosis
por: Kanno, Yosuke, et al.
Publicado: (2020)

Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin
Publicado: (1983)

Interleukin-6: a new therapeutic target in systemic sclerosis?
por: O'Reilly, Steven, et al.
Publicado: (2013)

Glutathione in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis
por: Kim, Kiyoung
Publicado: (2021)

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
por: Pretorius, Etheresia, et al.
Publicado: (2021)

Adenosine Receptors as Potential Therapeutic Analgesic Targets
por: Haddad, Mansour, et al.
Publicado: (2023)

RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
por: Du, Jun, et al.
Publicado: (2012)

New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?
por: González-Fernández, Carlos, et al.
Publicado: (2020)

Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
por: Melnikov, Mikhail, et al.
Publicado: (2021)

The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression
por: Kanno, Yosuke
Publicado: (2023)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
por: Khayat, Wujood, et al.
Publicado: (2022)

Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
por: Lopes, Douglas M., et al.
Publicado: (2022)

ER-α36: a novel biomarker and potential therapeutic target in breast cancer
por: Su, Xingyun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pgom2tl0prn9e2u63mm4p5c1m0